Patents by Inventor Daoqian CHEN

Daoqian CHEN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • A COMPOUND AS A THYROID HORMONE BETA RECEPTOR AGONIST AND USE THEREOF
    Publication number: 20240025875
    Abstract: A compound serving as a thyroid hormone ? receptor agonist and uses of the compound, also provided is a pharmaceutical composition comprising the compound. The compound or the pharmaceutical composition is applicable in preparing a medicament for preventing, treating, or alleviating thyroid hormone ? receptor agonist-modulated diseases, and specifically applicable in preparing a medicament for treating nonalcoholic fatty liver disease.
    Type: Application
    Filed: September 16, 2021
    Publication date: January 25, 2024
    Applicant: SUNSHINE LAKE PHARMA CO., LTD.
    Inventors: Zheng GU, Jianhao LI, Jianchao DENG, Yongxiang LI, Haoxiong QIN, Daoqian CHEN, Xiaomin ZHENG, Jianghong YU, Huantian ZHAO
  • METHOD FOR PREPARING GLUCOPYRANOSYL DERIVATIVES AND INTERMEDIATES THEREOF
    Publication number: 20230250121
    Abstract: A method for preparing glucopyranosyl derivatives as sodium dependent glucose cotransporter (SGLT) inhibitors, an intermediate thereof, and a method for preparing the intermediate.
    Type: Application
    Filed: July 7, 2021
    Publication date: August 10, 2023
    Applicant: SUNSHINE LAKE PHARMA CO., LTD.
    Inventors: Zheng GU, Tong QU, Wuyong WU, Weiming HUANG, Daoqian CHEN, Zongyuan ZHANG, Haoxiong QIN, Zheng LI, Weihui YUAN, Shijie NIU, Fei PENG, Tianyun WU
  • CHEMICAL COMPOUND AS THYROID HORMONE BETA RECEPTOR AGONIST AND USE THEREOF
    Publication number: 20220411400
    Abstract: A chemical compound as a thyroid hormone Beta receptor agonist and a use thereof, further including a pharmaceutical composition containing the chemical compound. The chemical compound or pharmaceutical composition can be used in the preparation of drugs for preventing, treating or mitigation of diseases mediated by agonistic thyroid hormone ? receptor, particularly for the preparation of drugs for treating non-alcoholic fatty liver diseases.
    Type: Application
    Filed: September 23, 2020
    Publication date: December 29, 2022
    Applicant: SUNSHINE LAKE PHARMA CO., LTD.
    Inventors: Zheng GU, Jianhao LI, Xinshan DENG, Zheng LI, Daoqian CHEN, Jianchao DENG, Aizhen LV, Jianyu LIU